Connect with us

Cannabis News

Missouri Marijuana Businesses Fined For Bringing Clones Across State Lines In Violation Of Rules

Published

5 months ago

on

“Some licensees believed they were allowed to bring in clones or tissue cultures and seeds on an ongoing basis.”

By Rebecca Rivas, Missouri Independent

At least seven Missouri marijuana growers have been fined in the past year for violating what’s known in the industry as the “immaculate origination rule.”

Marijuana cannot cross state lines because it is still illegal, and state law dictates that all marijuana must be grown within the state.

However, a year passes when a licensee passes an initial inspection when the state essentially turns a blind eye and puts its hands over its ears to how a cultivation facility begins its inventory.

It’s called the clean conception rule, and last year six facilities were fined $500,000 for breaking it.

A spokeswoman for Missouri’s Division of Cannabis Regulation said regulators “found that some licensees believed they were permitted to bring in clones or tissue cultures as well as seeds on an ongoing basis. However, this practice violates the seed sales tracking regulations.”

To keep up with customer preferences and demand, these companies brought in clones or starter plants and tissue cultures, a form of in vitro propagation, of popular plant varieties from other states.

“In lieu of penalties or other enforcement actions, these violations were settled for amounts ranging from $50,000 to $500,000, depending on the situation,” said Lisa Cox, a spokeswoman for the Missouri Department of Health and Aging Services, which oversees the cannabis regulatory division.

Licensees who have seen the largest fines are major players in other states, including the companies behind Good Day Farm and High Profile.

The combined fee for the four cultivation licenses representing Good Day Farm and Codes, shared management, was $347,495. Facilities are located in Columbia, Carrollton and Chaffee.

For High Profile, it was $500,000 at its O’Fallon cultivation facility.

Two smaller growers also saw fines of $20,000 and $50,000.

None of the licensees fined by the state returned The Independent’s request for comment.

‘mother plant’

Missouri cultivation facilities are approved to grow marijuana plants, and the harvest is sent to a manufacturing facility, which is then made into pre-rolls, edibles and other products.

Often, growers will develop a “mother plant” to collect clones or cuttings from the plant and put them in their pots. These are genetically identical to the plant from which they are cut.

But where does the mother plant come from?

In the first year of a facility, “the rules and the law are silent on how that happens,” Cox said.

After that, facilities can apply to the state for permission to bring in seeds for “continuing inventory needs,” or they can obtain clones from other licensed growers located in Missouri.

But the state fined several licensees last year for not following those rules, sending a clear message to all Missouri businesses that they must grow plants from seed or get starter plants from competitors.

Ryan Schepers, St. Louis Community College’s cannabis program professor, said that as a “plant nerd,” he doesn’t think starting from seed is necessarily difficult or a bad thing for industry innovation.

“I think a lot of cultivation centers are set up to take care of plants that are already established, and that would be a bit of a challenge,” he said.

But there’s nothing that “well-versed” plant growers working at the cultivation centers can’t handle, he said. He said the main challenge is the delay in production. It will take about a month to six weeks for a cannabis plant to start getting well established, he said, but they will be “pretty hardy plants.”

“Clones are obviously much easier to deal with,” he said.

But tissue cultures involve a small number of cells to begin with, he said, and that process can take as long as seeds to germinate.

He understands that it is difficult for companies to align the growing season of plants with the need to keep up with trends in other states. If a product sells very well in California, he said, “of course we’ll try to get the same thing in Missouri.”

However, he said the cultivation center can discourage him from trying new things. For the sake of his students, he hopes the emphasis will shift to growth and innovation.

“We at St Louis Community College really emphasize that our students are plant scientists who focus on cannabis,” he said.

Innovation can be difficult when federal and state laws are changing rapidly, he added.

The Independent asked if the state would consider allowing licensees to obtain clones in the future to continue popular varieties.

“The department was looking at the DEA’s guidelines that state that clones are not considered marijuana under federal law because of the low concentrations of Delta 9 (THC),” Cox said.

However, recent changes in federal law “may change the status of seeds and clones,” he said. He was referring to the hemp restrictions that were passed as part of the federal spending package last year and will go into effect in November.

“So the department will have to follow federal guidance,” Cox said, “and interpret how it develops over the next year before making any changes to rules or processes.”

This story was first published by the Missouri Independent.

Photo by Chris Wallis // Side Pocket Images.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Related Topics:
Continue Reading

Cannabis News

Massachusetts CCC pauses license applications

Published

13 hours ago

on

June 17, 2026

By











The Cannabis Control Commission, the government body that oversees the marijuana business in the state of Massachusetts (USA), has decided to temporarily stop accepting new license applications for growing marijuana, both indoors and outdoors. This hiatus officially began on June 16, 2026.

Anyone planning to apply for a new marijuana cultivation license after June 16, 2026 will not be able to do so while this suspension is in effect. The Commission will not accept such requests during this period.

There are two groups that can continue normally. First, anyone who submitted an application before June 16, 2026, will continue to review and process applications as usual. Second, applicants for specific programs designed to help communities historically affected by drug laws, known as the Social Equity Program and the Economic Empowerment Program, are exempt from this suspension if they apply for a smaller-scale “Microenterprise” license.

The suspension will be in effect for 120 days from June 16, 2026, which is currently scheduled to be lifted around mid-October 2026. However, the Commission has the power to terminate earlier or extend further, depending on market conditions.

Source: Massachusetts Cannabis Control Commission










Continue Reading

Cannabis News

Federal Marijuana Rescheduling ‘Does Not Appear To Apply’ To Washington Businesses, State Officials Say

Published

13 hours ago

on

June 17, 2026

By

Marijuana regulators in Washington say the Trump administration’s move to re-regulate cannabis at the federal level “doesn’t appear to apply” to the state’s businesses.

US Department of Justice in April He issued an order that immediately reclassified the state’s licensed medical cannabisas well as marijuana products approved by the Food and Drug Administration (FDA) under Schedule I through Schedule III of the Controlled Substances Act (CSA). A trial scheduled for this month will take place consider marijuana III.

“Washington does not issue licenses to producers, processors or retailers of medical cannabis,” the state’s Liquor and Cannabis Board (LCB) said in guidelines released Tuesday. “Instead, Washington has a single recreational market and within that market producers/processors can manufacture (DOH) compliant products, and certain retailers can sell DOH-compliant products to adult patients and all designated providers.”

“Therefore, Washington cannabis licensees do not appear to qualify as ‘state medical marijuana licensees’ and therefore may not be eligible for registration under the final Rule,” the agency said, referring to the Drug Enforcement Administration (DEA). Registration process for legal marijuana businesses in the state to take advantage of the federal benefits that come with the reform.

That said, the LCB “does not take a position if licensees decide to apply for federal registration,” the guidance continues. “If a licensee is seeking federal registration, we would be interested in learning about their experience and federal decisions.”

However, “based on our analysis, the federal reorganization in its current form does not appear to apply to cannabis licensees in Washington, primarily because of the legal framework governing recreational cannabis,” the LCB said.

The agency emphasized, however, that while it has consulted with the Cannabis Regulatory Association, the National Governors Association and industry stakeholders, its current opinion does not represent Washington’s formal opinion and “may not be our final interpretation as information is evolving and the decision may not rest with the state.”

“We await additional guidance from the federal agencies involved, new or updated federal agency processes and/or other federal procedures,” he said. he saidreferring to the next administrative hearing and Ongoing litigation calls into question the rescheduling of cannabis.

“The LCB recognizes that there are many cannabis growers, processors, and retailers actively involved in the production and sale of medical cannabis in Washington. These businesses may or may not be eligible to use the 280e tax deduction, and may also register with the DEA III. Ultimately, they have no input into whether their licensees meet the criteria for “state medical marijuana licensees,” as that determination can be made unilaterally by the DOJ within the meaning of the Final Rule. to reasonably interpret and determine that Washington cannabis licensees qualify as “state medical marijuana licensees.”

The US Treasury and Internal Revenue Service (IRS) said they plan to issued new tax guidelines for the marijuana industry after reprogramming. The reform will benefit state-licensed marijuana businesses by allowing them to take federal tax deductions that are currently prohibited under IRS Code Section III, known as Section 280E.

In California, regulators recently approved emergency rule changes to the state’s marijuana licensing process. to make it easier for companies to receive benefits In line with the Trump administration’s latest move to federally regulate medical cannabis.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

How New Zealand showed up in London’s cannabis industry

Published

2 days ago

on

June 16, 2026

By

The medical cannabis market is expected to grow from $47 billion to $149 billion by 2031, and New Zealand has a real role to play in that story. And thanks in large part to New Zealand Trade and Enterprise (NZTE), the government’s international business development agency, Puro is starting to play.

At Cannabis Europa 2026 London, NZTE hosted an evening event at the City Arts Bar with Puro, New Zealand companies Bluelab, Rua Bioscience and CannFX. Puro called it The NZ Room.

Beyond all things Kiwiana – including Puro brand kiwifruit, Kiwi’d – the room was filled with some pretty amazing people: Ivy League scientists, company founders, patients, advocates, industry players, government officials, Maori tribal leaders and a tough Scotsman. All in the same space with the same true passion for where this industry is going.

It was one of those rooms where conversations went well when they had to end. That’s usually a sign of something well done.

Made possible by NZTE
For Puro, the NZTE relationship has been formative. With ongoing support, Puro has entered the Australian market with 47 unique product SKUs and signed a £7 million supply agreement with UK distributor IPS Pharma.

NZTE understands the potential of the New Zealand cannabis industry. The willingness to support this nascent industry and put New Zealand in the spotlight at events like Cannabis Europa is very significant. New Zealand is a small country and the country’s credibility in international markets is built from relationship to relationship, room by room. NZTE helps build those rooms.

© Cigar

what’s next
For the first time, patients in the UK have access to medicinal cannabis grown in New Zealand. That’s the direct result of years of work by Puro’s team, but it’s not worth much if you can’t connect with buyers globally. Creating international relationships that events like Cannabis Europa make this possible.

“We are grateful for the extensive support from the New Zealand Government that drives our progress, including the Ministry of Primary Industries’ support for our genetic breeding, product innovation and market access goals. This collective effort from agencies such as the Ministry of Business, Innovation and Employment, NZTE and the New Zealand Export Credit Bureau ensures that Mail that started in London will continue to grow in Puro’s international goals,” he said. a statement

For more information:
clean
www.puro.co.nz

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media